Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.30 Thursday, 9th May 2024 GERN stock ended at $3.88. This is 1.84% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 3.16% from a day low at $3.80 to a day high of $3.92.
90 days $1.64 $4.30
52 weeks $1.64 $4.30

Historical Geron Corporation prices

Date Open High Low Close Volume
Jan 03, 2017 $2.10 $2.14 $2.06 $2.13 805 379
Dec 30, 2016 $2.09 $2.11 $2.03 $2.07 1 087 945
Dec 29, 2016 $2.04 $2.12 $2.04 $2.08 892 598
Dec 28, 2016 $2.08 $2.11 $2.06 $2.07 955 958
Dec 27, 2016 $2.15 $2.17 $2.07 $2.08 912 172
Dec 23, 2016 $2.02 $2.16 $2.02 $2.15 1 352 339
Dec 22, 2016 $2.07 $2.09 $2.03 $2.04 950 010
Dec 21, 2016 $2.15 $2.17 $2.07 $2.07 958 823
Dec 20, 2016 $2.13 $2.19 $2.11 $2.16 854 266
Dec 19, 2016 $2.14 $2.20 $2.12 $2.12 1 067 215
Dec 16, 2016 $2.12 $2.15 $2.08 $2.14 1 941 128
Dec 15, 2016 $2.04 $2.12 $2.02 $2.10 1 229 547
Dec 14, 2016 $2.04 $2.07 $1.99 $2.04 1 283 512
Dec 13, 2016 $2.07 $2.10 $2.00 $2.03 1 197 675
Dec 12, 2016 $2.07 $2.10 $2.03 $2.03 847 465
Dec 09, 2016 $2.11 $2.23 $2.06 $2.08 2 033 955
Dec 08, 2016 $2.08 $2.11 $2.03 $2.09 1 222 350
Dec 07, 2016 $2.10 $2.12 $2.02 $2.08 1 324 709
Dec 06, 2016 $2.09 $2.14 $2.05 $2.12 1 005 845
Dec 05, 2016 $2.05 $2.13 $2.02 $2.08 1 397 835
Dec 02, 2016 $1.96 $2.04 $1.96 $2.01 717 795
Dec 01, 2016 $2.04 $2.08 $1.95 $1.96 1 171 763
Nov 30, 2016 $2.09 $2.14 $2.02 $2.04 1 065 441
Nov 29, 2016 $2.12 $2.15 $2.08 $2.08 627 611
Nov 28, 2016 $2.23 $2.23 $2.11 $2.12 926 305
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT